rs9513851
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_052867.4(NALCN):c.3210C>T(p.Asn1070Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0645 in 1,611,716 control chromosomes in the GnomAD database, including 3,776 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.063 ( 332 hom., cov: 32)
Exomes 𝑓: 0.065 ( 3444 hom. )
Consequence
NALCN
NM_052867.4 synonymous
NM_052867.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.39
Publications
11 publications found
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
- congenital contractures of the limbs and face, hypotonia, and developmental delayInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- hypotonia, infantile, with psychomotor retardation and characteristic facies 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- digitotalar dysmorphismInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Freeman-Sheldon syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Sheldon-hall syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypotonia, infantile, with psychomotor retardation and characteristic faciesInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- temporal lobe epilepsyInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 13-101095633-G-A is Benign according to our data. Variant chr13-101095633-G-A is described in ClinVar as Benign. ClinVar VariationId is 262259.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NALCN | NM_052867.4 | c.3210C>T | p.Asn1070Asn | synonymous_variant | Exon 28 of 44 | ENST00000251127.11 | NP_443099.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0633 AC: 9608AN: 151756Hom.: 330 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9608
AN:
151756
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0627 AC: 15678AN: 249948 AF XY: 0.0670 show subpopulations
GnomAD2 exomes
AF:
AC:
15678
AN:
249948
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0647 AC: 94412AN: 1459842Hom.: 3444 Cov.: 31 AF XY: 0.0666 AC XY: 48389AN XY: 726226 show subpopulations
GnomAD4 exome
AF:
AC:
94412
AN:
1459842
Hom.:
Cov.:
31
AF XY:
AC XY:
48389
AN XY:
726226
show subpopulations
African (AFR)
AF:
AC:
2382
AN:
33386
American (AMR)
AF:
AC:
1413
AN:
44624
Ashkenazi Jewish (ASJ)
AF:
AC:
2465
AN:
26088
East Asian (EAS)
AF:
AC:
1324
AN:
39634
South Asian (SAS)
AF:
AC:
9760
AN:
85954
European-Finnish (FIN)
AF:
AC:
2525
AN:
53348
Middle Eastern (MID)
AF:
AC:
569
AN:
5756
European-Non Finnish (NFE)
AF:
AC:
69799
AN:
1110756
Other (OTH)
AF:
AC:
4175
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
4415
8830
13244
17659
22074
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2684
5368
8052
10736
13420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0633 AC: 9621AN: 151874Hom.: 332 Cov.: 32 AF XY: 0.0636 AC XY: 4719AN XY: 74242 show subpopulations
GnomAD4 genome
AF:
AC:
9621
AN:
151874
Hom.:
Cov.:
32
AF XY:
AC XY:
4719
AN XY:
74242
show subpopulations
African (AFR)
AF:
AC:
3074
AN:
41404
American (AMR)
AF:
AC:
744
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
AC:
347
AN:
3468
East Asian (EAS)
AF:
AC:
178
AN:
5164
South Asian (SAS)
AF:
AC:
538
AN:
4812
European-Finnish (FIN)
AF:
AC:
405
AN:
10546
Middle Eastern (MID)
AF:
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
AC:
4157
AN:
67948
Other (OTH)
AF:
AC:
111
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
459
917
1376
1834
2293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
229
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.